NIMODIPINE vs NIRSEVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIMODIPINE vs NIRSEVIMAB: Safety Overview
| Metric | NIMODIPINE | NIRSEVIMAB |
|---|---|---|
| Total FAERS Reports | 416 | 247 |
| Deaths Reported | 32 | 5 |
| Death Rate | 7.7% | 2.0% |
| Hospitalizations | 158 | 149 |
| Average Patient Age | 53.9 yrs | 0.3 yrs |
| % Female Patients | 62.3% | 42.3% |
| FDA Approval Date | Apr 17, 2007 | N/A |
| Manufacturer | Heritage Pharmaceuticals Inc. d/b/a A... | Sanofi Pasteur Inc. |
| Route | ORAL | INTRAMUSCULAR |
| Marketing Status | Discontinued | N/A |